• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

AARP: Part D may save seniors more than imported drugs


The Medicare Part D drug benefit could save seniors more money than reimported medications, according to an AARP analysis using information from the Medicare Rx plan finder tool. However, AARP, which offers a Part D drug plan, indicated it still supports reimportation legislation as a benefit for non-Medicare patients. The Canadian mail-order provider ADVCare Pharmacy disputed the AARP report as circumstantial and misleading because it was compared with one or two Rx plans for only five patients.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.